Nile Economic/ Business Outlook

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Nile Economic/ Business Outlook - Presentation Transcript

    1. This presentation is a high level summary of Nile Capital. For more information, contact: Bob Roach (617) 641-2865
    2. Nile Capital, LLC, (“Nile”) is a minority owned, boutique  investment firm focused upon closely held and publicly traded microcap companies Nile facilitates access to capital, exit/liquidity events, corporate  finance advisory, business development and strategic planning The principals of Nile have broad and varied experience in  private placements, venture capital, corporate finance, M&A, investor relations and operations Nile proactively works with clients in a variety of industries to  create and enhance shareholder value utilizing a strategic, operating and balance sheet perspective Page 2 Private and Confidential Nile Capital, LLC
    3. Facilitate access to acquisition and growth capital for select  companies with defined markets and extraordinary growth and ROI potential PIPE, venture capital, private equity and mezzanine debt financings  Industry agnostic, but specific analytical capabilities in Life Sciences and  technology companies Accelerate the achievement of business and financial objectives  Provide hands-on strategic, financial, operational and investor relations  expertise and assistance Utilize Nile’s internal resources as well as Nile’s strategic partner  relationships to enhance and maximize shareholder value Develop, drive and execute viable exit/liquidity scenarios  Merger & acquisition advisory  Wealth creation for principals and investors Page 3 Private and Confidential Nile Capital, LLC
    4. Decision modeling, economic valuation and strategic planning tools  for intellectual property-centric companies Life Sciences Expertise  200 years of combined experience in all aspects of pharmaceutical, R&D  and marketing (www.decisionoptions.com/html/people.htm) Risk and portfolio management of projects, companies and intellectual  property Business, technology, intellectual property and candidate valuation and  selection Technology and business due diligence  Licensing deal structuring and intermediation  Project design, capacity planning, manufacturing optimization and  incentive design Strategic and operational planning and management  Page 4 Private and Confidential Nile Capital, LLC
    5. Objective: Select the best projects/entities to maximize value  Value of intellectual property, product, R&D program, technology,  market position and brand Facilitate project selection, pricing, transactions and deal structuring  Objective: Allocate limited resources to create the best  portfolio to maximize enterprise value Allocation of all resources: people, skills, money, capacity and time  Objective: Design projects/entities to maximize value  Assist in deciding the timing and intensity of investments, nature of  investments, exit strategies, resource planning, as well as in-house versus outsourcing alternatives Page 5 Private and Confidential Nile Capital, LLC
    6. Nile provides a platform for transaction professionals to operate and close  transactions under the umbrella of a FINRA-licensed firm Up to 75% payout of commissions (including equity)  Leverage Nile’s network of professionals  “Eat what you kill” environment  Nile focus on being more than an investment bank, but a partner that can  facilitate: Corporate finance advisory (PIPE’s, venture capital, private equity, valuation  and M&A) Investor relations  Business development, operational and marketing support for companies in  life sciences, software and clean energy Contract CFO  Possible future service offerings in investment research and investment  advisory Page 6 Private and Confidential Nile Capital, LLC
    7. Fear and uncertainty rule the markets  No indication that Washington has a handle on a solution to the economic  malaise Long on rhetoric, short on details  The $787 billion pork-laden (but no earmarks) stimulus bill includes  approximately $132.7 billion of infrastructure spending (17%) and $50 billion allocated to energy (6%) Venture capital investments in 2008 declined by 8% to $28.3 billion from  2007 levels Q4 2008 venture capital investments of $5.4 billion represent a 26% decrease  from Q3 and are at their lowest level since Q1 2005 Potential adverse affects of proposed change in tax structure of carried  interest from capital gains to ordinary income status Page 7 Private and Confidential Nile Capital, LLC
    8. Energy  $50 billion of stimulus spending for renewable and clean energy (mitigated by  a global decline in government subsidies) Passage of a Cap & Trade program should increase overall electricity prices  making renewable energy more economically feasible Renewable energy production in the US expected to grow from 8.4% to  12.5% in 2030 54% growth in 2008 VC investments in clean energy to $4.1 billion  Information technology  Windfall from $19 billion stimulus allocation to healthcare IT  Financial Services  Factoring, micro-lending and other opportunities that take advantage of the  credit crunch Page 8 Private and Confidential Nile Capital, LLC
    9. Life Sciences  Attractive exit/liquidity multiples possible compared to other sectors, even in  tough markets Value inflection points (Phase II, Phase III, FDA approval)  Challenges to the large pharmaceutical model has made them active acquirers  and competitors for high quality assets Impending patent expirations of major prescription drug revenue drivers in  the 2010-2013 period The traditional VC biotech model is broken (our opinion) creating  opportunities for alternative financing and liquidity structures and a “buyer’s” market Adverse factors:  2008 VC investments in Life Sciences declined 15% to $8 billion  Potential reductions in patent protection favoring generic manufacturers may have significant  adverse affects on R&D Page 9 Private and Confidential Nile Capital, LLC
    10. Typical clients range from early stage to $50 million in revenue  Investment banking plus other services and strategic relationships to drive  wealth creation Platform for experienced transaction professionals  Industry opportunities  Energy  Life Sciences  Information Technology  Financial Services  From uncertainty comes opportunity!! Page 10 Private and Confidential Nile Capital, LLC
    11. •Venture Capital Opportunities Robert G. Roach, Jr. Boston, MA •Acquisitions/roll ups CEO & Managing Director •PIPES roach@nilecapital.com •Hedge Fund Marketing •Contract CFO •Investment Advisor •Acquisitions/roll ups Graham Phillips Los Angeles, CA •PIPES Managing Director •Later Stage Opportunities gphillips@nilecapital.com •Hedge Fund Marketing •Contract CFO •Compliance & Operations Mary Lecca Boston, MA •Transaction Support Vice President &Compliance Officer •Investment Advisor mlecca@nilecapital.com •Hedge Fund Marketing Debra Goundrey New York, NY Vice President dgoundrey@nilecapital.com •Acquisitions/roll ups Greg Harrison Los Angeles, CA •PIPES Vice President •Later Stage Opportunities gharrison@nilecapital.com •Venture Capital Opportunities Henry Noel Boston, MA •Acquisitions/roll ups Vice President •PIPES hnoel@nilecapital.com •Investor Relations Christine Petraglia New York, NY •PIPES Vice President cpetraglia@nilecapital.com Page 11 Private and Confidential Nile Capital, LLC
    12. VRP Enterprises: Vehicle replacement protection company. Nile principals raised a small Angel  capital round for this developmental stage provider of vehicle replacement protection for US car buyers. Nile also provided business development introductions. Ability Reinsurance: Reinsurance company. Nile principals drafted the business plan and secured a  $300MM private equity commitment to fund a start-up reinsurance company. Fulfillment Plus: Call center and fulfillment company. Nile principals assumed the role of COO/CFO  for the company. During a three year period, the company achieved a revenue increase from $9MM to $43MM. In addition, $3MM of expansion capital was raised from Angels and Nile principals developed comprehensive business plan financial and pricing models to drive and support profitable growth. Time Domain Corporation: Ultra-wideband telecommunications technology company. Nile  principals raised $2.5MM of venture capital for this developmental stage technology company. Advanced Radio Telecom: Fixed broadband wireless services company. Nile principals assisted ART  in raising $7.5 million in institutional venture capital and $2+ million in Angel capital. The principals also performed M&A advisory on three acquisitions, sourced a strategic relationship, and marketed the company to Wall Street investment firms, which lead to the eventual IPO. Page 12 Private and Confidential Nile Capital, LLC
    SlideShare Zeitgeist 2009

    + Nile Capital, LLCNile Capital, LLC Nominate

    custom

    372 views, 0 favs, 0 embeds more stats

    Presentation to the Boston chapter of the National more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 372
      • 372 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 4
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories